Zebra Capital Management LLC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 138 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zebra Capital Management LLC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$601,000
-6.8%
55,618
-11.6%
0.18%
-9.5%
Q3 2016$645,000
-7.1%
62,903
+18.3%
0.20%
-16.6%
Q2 2016$694,000
+967.7%
53,177
+304.7%
0.24%
+346.3%
Q2 2013$65,00013,1390.05%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders